$60,000 of MCKESSON CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the pharmaceutical supply chain and drug shortages. Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act."
You can find more data on corporate lobbying on Quiver Quantitative.
MCK Congressional Stock Trading
Members of Congress have traded $MCK stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $MCK stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/18 and 2 sales worth up to $30,000 on 12/19, 08/05.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 10/10.
- REPRESENTATIVE JONATHAN L. JACKSON sold up to $15,000 on 10/08.
- REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 1 purchase worth up to $15,000 on 09/10 and 1 sale worth up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
MCK Insider Trading Activity
MCK insiders have traded $MCK stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $MCK stock by insiders over the last 6 months:
- BRIAN S. TYLER (Chief Executive Officer) has made 0 purchases and 2 sales selling 23,860 shares for an estimated $16,503,842.
- NAPOLEON B JR RUTLEDGE (SVP, Controller & CAO) has made 0 purchases and 2 sales selling 658 shares for an estimated $501,823.
- THOMAS L RODGERS (EVP, Chief Strategy & BDO) sold 276 shares for an estimated $225,265
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MCK Hedge Fund Activity
We have seen 807 institutional investors add shares of MCK stock to their portfolio, and 762 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 2,020,197 shares (-42.0%) from their portfolio in Q3 2025, for an estimated $1,560,682,990
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,083,682 shares (+83.7%) to their portfolio in Q3 2025, for an estimated $837,187,692
- FMR LLC added 781,659 shares (+36.4%) to their portfolio in Q3 2025, for an estimated $603,862,843
- GQG PARTNERS LLC removed 490,526 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $378,950,956
- HOLOCENE ADVISORS, LP removed 316,205 shares (-83.2%) from their portfolio in Q3 2025, for an estimated $244,281,010
- TWO SIGMA ADVISERS, LP removed 284,300 shares (-95.0%) from their portfolio in Q3 2025, for an estimated $219,633,122
- TWO SIGMA INVESTMENTS, LP removed 283,480 shares (-97.9%) from their portfolio in Q3 2025, for an estimated $218,999,639
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MCK Analyst Ratings
Wall Street analysts have issued reports on $MCK in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 11/06/2025
- Baird issued a "Outperform" rating on 11/06/2025
- JP Morgan issued a "Overweight" rating on 09/26/2025
- Citigroup issued a "Buy" rating on 09/24/2025
- Morgan Stanley issued a "Overweight" rating on 09/24/2025
- Deutsche Bank issued a "Buy" rating on 09/24/2025
- Leerink Partners issued a "Outperform" rating on 09/24/2025
To track analyst ratings and price targets for MCK, check out Quiver Quantitative's $MCK forecast page.
MCK Price Targets
Multiple analysts have issued price targets for $MCK recently. We have seen 14 analysts offer price targets for $MCK in the last 6 months, with a median target of $862.0.
Here are some recent targets:
- Glen Santangelo from Barclays set a target price of $960.0 on 12/09/2025
- Stephen Baxter from Wells Fargo set a target price of $914.0 on 11/10/2025
- Eric Coldwell from Baird set a target price of $927.0 on 11/06/2025
- Erin Wright from Morgan Stanley set a target price of $916.0 on 11/06/2025
- Kevin Caliendo from UBS set a target price of $980.0 on 11/06/2025
- Brian Tanquilut from Jefferies set a target price of $900.0 on 10/14/2025
- Lisa Gill from JP Morgan set a target price of $853.0 on 09/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
